Association between atherosclerotic aortic plaques and left ventricular hypertrophy in patients with cerebrovascular events

Stroke

Volumn 37, Issue 4, 2006, Pages 958-962

  Hueb, João Carlos ^a,c   Zanati, Silméia G ^a   Okoshi, Katashi ^a   Raffin, César N ^a   De Arruda Silveira, Liciana Vaz ^b   Matsubara, Beatriz B ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Faculdade de Medicina Veterinária e Zootecnia   (Brazil)

Author keywords

Echocardiography; Left ventricular hypertrophy; Stroke; Transient ischemic attack

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROMA; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; EVALUATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RANK SUM TEST; RISK ASSESSMENT; STATISTICAL ANALYSIS; STROKE; STUDENT T TEST; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; AGE; AORTA DISEASE; ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; INCIDENCE; MIDDLE AGED; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; CEREBROVASCULAR DISORDERS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33645823561     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000208112.18484.e6     Document Type: Article

References (49)

1. Kronzon I, Tunick PA. Atheromatous disease of the thoracic aorta: pathologic and clinical implications. Ann Intern Med. 1997;126:629-637.
2. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1999;33:899-907.
3. Kessler C, Mitusch R, Guo Y, Rosengart A, Sheikhzadeh A. Embolism from the aortic arch in patients with cerebral ischemia. Thromb Res. 1996;84:145-155.
4. Mitusch R, Tepe C, Stierle U, Schwabe K, Potratz J, Kummer-Kloess D, Kessler C, Sheikhzadeh A. Determinants of arterial embolism with special reference to atheromatous changes of the thoracic aorta. Z Kardiol. 1995;84: 198-204.
5. Nihoyannopoulos P, Athanasopoulos G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol. 1993;71:1208-1212.
6. Heinzlef O, Cohen A, Amarenco P. Atherosclerotic aortic plaques and risk of embolic stroke. Rev Neurol. 2001;157:619-631.
7. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol. 2000;35:545-554.
8. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Méd. 1992;326:221-225.
9. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG. Atherosclerotic disease of the aortic arch and risk of ischemic stroke. N Engl J Med. 1994;331:1474-1479.
10. Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke. 1992;23:1056-1061.
11. Karalis DG, Chandrasekaran K, Victor MF, Ross JJ, Mintz GS. Recog-nition and embolic potential of intraortic atherosclerotic debris. J Am Coll Cardiol. 1991;17:73-78.
12. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995;26:218-224.
13. Montgomery DH, Vervesis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: transesophageal echocardiographic study. J Am Cardiol. 1996;27: 95-101.
14. Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolismosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol. 1993;71:1208-1217.
15. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000;139:329-336.
16. Tunick PA, Perez BA, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991;115:423-427.
17. Vaduganathan P, Ewton A, Nagueh SF, Welbaecher DG, Safi HJ, Zoghbi WA. Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography. J Am Coll Cardiol. 1977;30:357-363.
18. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994;23:1085-1090.
19. Click LC, Espinosa RE, Khandheria BK. Source of embolism. In: Freeman WK, ed. Transesophageal Echocardiography. Boston, Mass: Little Brown and Company; 1994:469-499.
20. Toyoda K, Yasaka M, Yamashita N, Imakita S, Yamaguchi T. Transesophageal echocardiography for detecting intracardiac thrombi in embolic stroke. Angiology. 1993;44:376-383.
21. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;26:727-733.
22. Metzger R, Bohle RM, Chumachenko P, Danilov SM, Franke FE. CD143 in the development of atherosclerosis. Atherosclerosis. 2000;150:21-31.
23. Scholkens BA, Landgraf W. ACE inhibition and atherosclerosis. Can J Physiol Pharmacol. 2002;80:354-359.
24. Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun. 1996;226: 862-868.
25. Sleigth P. The hope study (Heart outcomes prevention evaluation). J Renin Angiotensin Aldosterone Syst. 2000;1:18-20.
26. Wilfert K, Guski H, Persson PB, Stauss HM. Cardiovascular responses to angiotensin II in atherosclerosis. Acta Physiol Scand. 2002;176:95-100.
27. Miyazaki M, Takai S. Involvement of angiotensin II in development of atherosclerosis. Nippon Rinsho. 2002;60:1904-1910.
28. Hope S, Breccher P, Chobanian AV. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis. Am J Hypertens. 1999;12:28-34.
29. Schiffrin EL. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens. 2002;15:115S-22S.
30. Lonn E. Dose response of ACE inhibitors: implications of the SECURE trial. Curr Control Trials Cardiovasc. 2001;2:15515-15519.
31. Frohligh ED, Dustan HP, Marcus M. The heart in hypertension. N Engl J Med. 1992;327:998-1008.
32. Martinez Filho EE, Balestrini CS. Hipertrofia ventricular esquerda e hipertensao. Hipertensão. 2002;5:92-102.
33. Schunkbert H, Hense H, Holmer SR, Stender M, Perz S, Keil U Lorell B, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
34. Lechin M, Quimones MA, Omran A, Hill R, Yu Q, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, Marian AJ. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995;92:1808-1812.
35. Izar COM, Ihara SSM, Relvas WGM. Preditores genéticos da aterosclerose coronariana. Rev Soc Cardiol Estado São Paulo. 2000;10:761-768.
36. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive Heart disease and the role of hormones. Hypertension. 1994;6:869-877.
37. Sahn DJ, DeMaria A, Kissio J, Weiman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1079.
38. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O" B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction of echocardiography: fron the investigators of Concensus of Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996;9:736-760.
39. Grant C, Greene DG, Bunnel IL. Left ventricular enlargement and hypertrophy. A clinical and angiographic study. Am J Med. 1965;39: 895-907.
40. Siogren AL. Left ventricular wall thickness in patients with circulatory overload of the left ventricle. Ultrasonic, physical, electrocardiographic and radiologic correlations. Ann Clin Res. 1972;4:310-319.
41. Bennett DH, Evans DW. Correlation of left ventricular mass determined by echocardiography with vectorcardiographic and electrocardiographic voltage measurements. Br Heart J. 1974;36:981-993.
42. Norman GR. Streiner DL. Biostatistics: The Bare Essentials. St. Louis, Mo: Mosby Book; 1994.
43. Goodman LA. Simultaneous confidence intervals for contrast among multinomial populations. Ann Math Stat. 1964;35:716-725.
44. Goodman LA. On simultaneous confidence intervals for multinomial proportions. Tedinometrics. 1995;7:247-254.
45. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson T, Ambrosio J. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation. 2001;104:2039-2044.
46. Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C, Lembo G. Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke. 2003;34:1766-1770.
47. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and risk of ischemic stroke. Stroke. 2003;34: 2380-2384.
48. Janicki JS, Matsubara BB. Myocardial collagen and left ventricular diastolic dysfunction. In: Gaasch W, LeWinter M, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia, Pa: Lea & Febiger; 1994:125-140.
49. Clarkson PBM, Wheleldon NM, MacLeod C, Tennent M, MacDonald TM. Effects of angiotensin II and aldosterone on diastolic function in vivo normal man. Clin Sci. 1994;87:397-401.